Batash Endoscopic Weight Loss
- Company typePrivate
- Founded1992
- HeadquartersRego Park, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
Batash Endoscopic Weight Loss firmographics
Firmographics- Name
- Batash Endoscopic Weight Loss
- Legal name
- Batash Endoscopic Weight Loss Center
- Website
- https://batashmedical.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Batash Endoscopic Weight Loss industry classification
Industry- Product category
- Medical Weight Loss Services
- NAICS
- Freestanding Ambulatory Surgical and Emergency Centers (621493), Diet and Weight Reducing Centers (812191)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Obesity Medicine & Weight Management (HLAKADAL)
Keywords
Where Batash Endoscopic Weight Loss is headquartered
LocationHeadquarters
- HQ city
- Rego Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Batash Endoscopic Weight Loss business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Endoscopic Weight Loss Procedures: One-time surgical fees for procedures including Suture Sculpt ESG, gastric balloons, and revision procedures. Fees vary by procedure type and are typically paid prior to or at time of service.
- Aesthetic Surgery Services: Surgical aesthetic procedures including liposuction, tummy tuck, breast augmentation, breast lift performed by Dr. Yoel Rojas at Batash Aesthetics.
- RX Weight Loss Program: Monthly prescription weight loss medication programs including peptides and ongoing medical supervision.
- Financing Programs: Partnership with CareCredit, Alphaeon, and Cherry for patient financing, enabling monthly payment plans for procedures.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Suture Sculpt ESG: Non-surgical endoscopic sleeve gastroplasty |
| One time/ perpetual license | Pay-as-you-go | Liposuction procedure |
| One time/ perpetual license | Pay-as-you-go | Tummy Tuck surgery |
| Subscription | Monthly | Financing through Cherry |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Batash Endoscopic Weight Loss product offering
Product offeringCore offering
Batash Endoscopic Weight Loss provides non-surgical and minimally invasive endoscopic weight loss procedures, including the proprietary Suture Sculpt (ESG), Suture Resculpt (gastric bypass revision), and intragastric balloon systems (Orbera, Spatz3, Allurion). The practice also delivers supporting programs including a monthly RX Weight Loss subscription, Peptides RX, and a full suite of aesthetic services such as liposuction, tummy tuck, breast augmentation and lift, arm/thigh lift, mommy makeover, and BodyTite. Care is delivered on a same-day outpatient basis across two clinic locations.
Product overview
Batash Endoscopic Weight Loss Center operates as a medical practice offering a comprehensive portfolio of non-surgical and surgical weight loss and aesthetic procedures. The core offerings center on three primary endoscopic weight loss systems: the Suture Sculpt (Endoscopic Sleeve Gastroplasty/ESG) for long-term weight loss achieving 28-30% total body weight reduction, the Gastric Balloon Weight Loss System providing short-term 6-8 month solutions with 18-21% weight loss using Orbera, Spatz3, and Allurion balloons, and the Suture Resculpt for revision procedures. Supporting the core procedures, the practice offers medical weight loss programs including RX Weight Loss and Peptides RX. Under the Batash Aesthetics sub-brand, the practice provides surgical body contouring and cosmetic procedures including Liposuction, Tummy Tuck, Breast Augmentation, Breast Lift, Arm Lift, Thigh Lift, BodyTite, Mommy Makeover, and Facial Rejuvenation—all performed by Dr. Yoel Rojas. The practice operates from two locations in Queens, NY and Miami, FL.
Differentiator
Problem solved
Functional benefit
Brands
- Suture Sculpt: Endoscopic Sleeve Gastroplasty (ESG) procedure - a long-term non-surgical weight loss solution that reduces stomach size using sutures placed from inside without incisions.
- Suture Resculpt
- Gastric Balloon Weight Loss System
- Batash Aesthetics
Products and services
- Suture Sculpt Weight Loss System (Endoscopic Sleeve Gastroplasty / ESG) Non-surgical, incisionless endoscopic procedure that reduces stomach volume using internal suturing to achieve weight loss; designed for adults seeking an alternative to traditional bariatric surgery with 1-3 day recovery.
- Gastric Balloon Weight Loss System (Orbera, Spatz3, Allurion)
Quantifiable outcome
- 28-30% total body weight loss with Suture Sculpt ESG procedure
- +5 more outcomes
Companies that use Batash Endoscopic Weight Loss
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles1 record
Batash Endoscopic Weight Loss technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature3 records
Batash Endoscopic Weight Loss partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Batash Endoscopic Weight Loss competitors and assessment
Company assessmentDirect peers
- True You Weight Loss: Founded by Dr. Christopher McGowan, one of the most prolific ESG and endoscopic weight loss practitioners in the U.S. Operates clinics in North Carolina and offers the same core procedures (ESG, gastric balloons, bariatric endoscopy revisions) to a similar patient segment. The most direct clinical and operational comparable to Batash.
- New York Bariatric Group: Multi-location bariatric surgery and weight loss practice in the New York metro area offering gastric sleeve, gastric bypass, and LAP-BAND procedures. Targets the same BMI 25+ patient population in Batash's core geography with surgical alternatives — represents both a competitor and a referral source for complex cases.
- Princeton Center for Bariatric Surgery: Regional bariatric and weight loss practice serving New Jersey and the greater New York metro area. Offers surgical and non-surgical weight loss options targeting a similar affluent, health-conscious patient demographic in the Northeast corridor.
- Endobariatric: Dr. Christopher McGowan's brand and clinical platform for endoscopic bariatric procedures, including ESG and revision procedures. Directly comparable in clinical approach, patient demographic, and procedure mix to Batash's Suture Sculpt offerings.
Broad incumbents
- NYU Langone Weight Management Program: Academic medical center offering comprehensive medical, endoscopic, and surgical weight management in New York City. Operates in the same metro as Batash's Queens headquarters with broader institutional infrastructure and insurance participation, representing a larger but less specialized competitor.
- Mount Sinai Weight Management: Academic medical center offering bariatric surgery and medical weight management programs in the New York metro area. Provides integrated care including insurance-covered surgical options that compete with Batash's cash-pay endoscopic approach on price for some patient segments.
- Cleveland Clinic Bariatric and Metabolic Institute: Large academic medical center offering comprehensive bariatric surgery, endoscopic procedures, and medical weight management nationally. Represents the institutional incumbent model with insurance coverage and research-driven protocols that Batash competes against for complex and out-of-state patients.
Emerging players
- Calibrate: Telehealth metabolic reset program combining GLP-1 medication prescribing with coaching. Targets the same BMI 25+ weight loss patient demographic through a virtual, lower-cost channel. Represents the most direct digital threat to cash-pay endoscopic procedures by offering accessible pharmacotherapy alternatives.
- Ro: Direct-to-consumer telehealth platform offering weight loss programs including GLP-1 prescriptions (Wegovy, Zepbound) at $145/month. Competes for the same price-sensitive patient segment with a fully virtual, lower-cost model and is rapidly scaling its obesity care vertical.
- Found: Telehealth weight management platform combining prescription medication (including GLP-1s) with personalized coaching. Targets the same patient demographic as Batash but through a virtual, primarily medication-driven care model that is cheaper and more accessible than endoscopic procedures.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Batash Endoscopic Weight Loss social profiles
Digital presenceBatash Endoscopic Weight Loss financial estimates
Financial estimateRevenue estimate
Valuation estimate
Batash Endoscopic Weight Loss leadership team
Management profileNumber of profiles
Profiles6 records
Batash Endoscopic Weight Loss funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Batash Endoscopic Weight Loss M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Batash Endoscopic Weight Loss
What does Batash Endoscopic Weight Loss do?
Batash Endoscopic Weight Loss provides non-surgical and minimally invasive endoscopic weight loss procedures, including the proprietary Suture Sculpt (ESG), Suture Resculpt (gastric bypass revision), and intragastric balloon systems (Orbera, Spatz3, Allurion). The practice also delivers supporting programs including a monthly RX Weight Loss subscription, Peptides RX, and a full suite of aesthetic services such as liposuction, tummy tuck, breast augmentation and lift, arm/thigh lift, mommy makeover, and BodyTite. Care is delivered on a same-day outpatient basis across two clinic locations.
Is Batash Endoscopic Weight Loss a public or private company?
Batash Endoscopic Weight Loss is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Batash Endoscopic Weight Loss founded?
Batash Endoscopic Weight Loss was founded in 1992. It employs 11 to 50 people.
Where is Batash Endoscopic Weight Loss based?
Batash Endoscopic Weight Loss is headquartered in Rego Park, United States, in the North America region.
How does Batash Endoscopic Weight Loss make money?
Four revenue lines are on record. Endoscopic Weight Loss Procedures are the primary driver. The others are aesthetic Surgery Services, RX Weight Loss Program and financing Programs.
Who are Batash Endoscopic Weight Loss's main competitors?
Direct peers on record are True You Weight Loss, New York Bariatric Group, Princeton Center for Bariatric Surgery and Endobariatric. Broad incumbents are NYU Langone Weight Management Program, Mount Sinai Weight Management and Cleveland Clinic Bariatric and Metabolic Institute. Emerging players are Calibrate, Ro and Found.
Does Batash Endoscopic Weight Loss have an API?
No public API is recorded for Batash Endoscopic Weight Loss.
What industry is Batash Endoscopic Weight Loss in?
Batash Endoscopic Weight Loss's product category is Medical Weight Loss Services. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management. Its NAICS code is 621493 and its SIC code is 8090.